You are here: Industry Insights > metastatic

News List

Metastatic melanoma treatment gets Breakthrough Therapy Designation europeanpharmaceuticalreview
August 06, 2019
Breakthrough Therapy Designation has been granted for investigational agent bempegaldesleukin in combination with nivolumab.
TYME Technologies, NYU Langone to Advance Metastatic Cancer Treatment contractpharma
July 31, 2019
Aims to examine TYME’s metabolism-based cancer treatment, SM-88.
FDA Approves Keytruda (pembrolizumab) for the Treatment of Metastatic Small Cell Lung Cancer (SCLC) drugs
June 19, 2019
FDA Approves Keytruda (pembrolizumab) for the Treatment of Metastatic Small Cell Lung Cancer (SCLC).
ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer drugs
June 06, 2019
Enzalutamide Beneficial in Metastatic Prostate Cancer.
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer worldpharmanews
May 10, 2019
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer.
Immunocore’s Lead Asset Tebentafusp Gains Fast Track Designation for Metastatic Uveal Melanoma drugs
April 17, 2019
Immunocore’s Lead Asset Tebentafusp Gains Fast Track Designation for Metastatic Uveal Melanoma.
FDA approves first targeted therapy for metastatic bladder cancer worldpharmanews
April 16, 2019
FDA approves first targeted therapy for metastatic bladder cancer.
Drug combination may become new standard treatment for advanced kidney cancer europeanpharmaceuticalreview
February 19, 2019
Immunotherapy drug plus targeted agent provided better progression-free survival and shrank tumors in more patients than standard one-drug treatment…
AstraZeneca's Imfinzi immunotherapy combo fails to show benefit in lung cancer pharmafile
November 19, 2018
AstraZeneca has revealed that its immunotherapy combo of Imfinzi (durvalumab) and tremelimumab failed to meet its primary endpoint in a recent
Taking a standard prostate cancer drug with food boosts impact europeanpharmaceuticalreview
April 04, 2018
By taking Zytiga with a low-fat meal could decrease the daily dose and prevent digestive issues…